Literature DB >> 1635341

Distribution of the alpha 1 and alpha 2 chains of collagen IV and of collagens V and VI in Alport syndrome.

C E Kashtan1, Y Kim.   

Abstract

We compared the distribution of the alpha 1 and alpha 2 chains of collagen IV and of collagens V and VI in glomeruli of males with Alport syndrome to their distribution in normal glomeruli and glomeruli from patients with non-Alport renal diseases. alpha 1(IV), alpha 2(IV), collagen V and collagen VI are normally restricted to the mesangium and the subendothelial aspect of the glomerular basement membrane (GBM). In contrast, these proteins were present throughout the entire width of the GBM in Alport glomeruli. These alterations were apparent in "early" Alport glomeruli, that is, those exhibiting minimal abnormalities by light microscopy, and they were further accentuated in sclerosing Alport glomeruli. Obsolescent Alport glomeruli, in which the capillary tuft had collapsed and few remaining cell nuclei were present, exhibited nearly complete loss of alpha 1(IV) and alpha 2(IV), like obsolescent glomeruli in non-Alport diseased kidneys. However, the matrix of obsolescent Alport glomeruli stained intensely for collagen V and collagen VI, while these collagen types were not prominent in obsolescent glomeruli of non-Alport diseases kidneys. These observations suggest that the process of glomerulosclerosis in Alport kidneys has attributes unique to this disease. It would also appear that mutations affecting the Alport gene product have secondary effects on the distribution of other GBM constituents.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1635341     DOI: 10.1038/ki.1992.269

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  31 in total

1.  Immunohistochemical distribution of type VI collagen in developing human kidney.

Authors:  G Magro; S Grasso; A Colombatti; M Lopes
Journal:  Histochem J       Date:  1996-05

Review 2.  Organogenesis of the kidney glomerulus: focus on the glomerular basement membrane.

Authors:  Jeffrey H Miner
Journal:  Organogenesis       Date:  2011-04-01       Impact factor: 2.500

3.  Glomerular expression of type IV collagen chains in normal and X-linked Alport syndrome kidneys.

Authors:  L Heidet; Y Cai; L Guicharnaud; C Antignac; M C Gubler
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

4.  Differential expression of laminin isoforms in diabetic nephropathy and other renal diseases.

Authors:  Suman Setty; Alfred A Michael; Alfred J Fish; S Michael Mauer; Ralph J Butkowski; Ismo Virtanen; Youngki Kim
Journal:  Mod Pathol       Date:  2012-02-17       Impact factor: 7.842

5.  Two Specific Sulfatide Species Are Dysregulated during Renal Development in a Mouse Model of Alport Syndrome.

Authors:  Megan M Gessel; Jeffrey M Spraggins; Paul A Voziyan; Dale R Abrahamson; Richard M Caprioli; Billy G Hudson
Journal:  Lipids       Date:  2019-06-13       Impact factor: 1.880

6.  Absence of the alpha6(IV) chain of collagen type IV in Alport syndrome is related to a failure at the protein assembly level and does not result in diffuse leiomyomatosis.

Authors:  K Zheng; S Harvey; Y Sado; I Naito; Y Ninomiya; R Jacobs; P S Thorner
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

7.  Rapid identification of a disease allele in mouse through whole genome sequencing and bulk segregation analysis.

Authors:  Carrie N Arnold; Yu Xia; Pei Lin; Charles Ross; Martin Schwander; Nora G Smart; Ulrich Müller; Bruce Beutler
Journal:  Genetics       Date:  2010-12-31       Impact factor: 4.562

Review 8.  Alport syndrome and Pierson syndrome: Diseases of the glomerular basement membrane.

Authors:  Steven D Funk; Meei-Hua Lin; Jeffrey H Miner
Journal:  Matrix Biol       Date:  2018-04-16       Impact factor: 11.583

Review 9.  Familial hematuria.

Authors:  Clifford E Kashtan
Journal:  Pediatr Nephrol       Date:  2007-10-02       Impact factor: 3.714

10.  Ventricular septal defect in a child with Alport syndrome: a case report.

Authors:  Pier Paolo Bassareo; Andrea Raffaele Marras; Giuseppe Mercuro
Journal:  BMC Cardiovasc Disord       Date:  2010-10-05       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.